Histologic changes in the skin of the rhino mouse (hrrhhrrh) induced by retinoids
- PMID: 6586859
- DOI: 10.1111/1523-1747.ep12261472
Histologic changes in the skin of the rhino mouse (hrrhhrrh) induced by retinoids
Abstract
The effects of four retinoids, all-trans-retinoic acid (RA), 13-cis-retinoic acid (13-cis-RA), aromatic retinoid, and arotinoid ethyl ester ( arotinoid ) were examined on the skin of the rhino mouse. Rhino mouse skin is characterized by the presence of keratin-containing utricles attached to the epidermis, and subcutaneous cysts, both of which are derived from hair follicles. The utricles were examined in horizontal sheets of epidermis, and in vertical histologic sections. After applications of 0.1 ml of 0.1% RA, 0.1% 13-cis-RA, 0.1% aromatic retinoid, or 0.001% arotinoid in acetone to the dorsal skin for 5 days a week for 2 weeks, there was a reduction of utricle diameter to 45%, 52%, 30%, and 31% of acetone-treated controls, respectively. Histologic examination of the epidermis revealed that a dose-dependent hyperplasia and thickening of the epidermis and the stratum granulosum was induced by the retinoids when given at subtoxic doses, being most marked after arotinoid or RA. The thickness of the walls of the utricles also increased with increasing dose of retinoid, paralleling the changes in the epidermis. After doses of 0.1% RA and 0.001% arotinoid , the utricles resembled the hair follicles of hairless mice. Hyperplasia of the epidermis appears to be a primary effect of retinoids or rhino mouse skin. Hyperproliferation of the utricle wall is accompanied by a reduction in the size of the utricle lumen, preceding eventual differentiation of the utricles to normal-looking pilar units.
Similar articles
-
Induction of ornithine decarboxylase activity and DNA synthesis in hairless mouse epidermis by retinoids.Cancer Res. 1983 Nov;43(11):5174-7. Cancer Res. 1983. PMID: 6616453
-
Pharmacokinetics of topically applied radiolabeled retinoids in hairless mouse epidermis and dermis after single applications.J Invest Dermatol. 1985 Mar;84(3):184-6. doi: 10.1111/1523-1747.ep12264729. J Invest Dermatol. 1985. PMID: 3973402
-
Retinoids in aging.Clin Dermatol. 1996 Mar-Apr;14(2):207-15. doi: 10.1016/0738-081x(95)00156-a. Clin Dermatol. 1996. PMID: 9117987 Review. No abstract available.
-
New indications and new retinoids.Dermatologica. 1987;175 Suppl 1:182-95. doi: 10.1159/000248882. Dermatologica. 1987. PMID: 3319725 Review.
-
Nature of skin fragility in patients receiving retinoids for systemic effect.Arch Dermatol. 1981 Oct;117(10):611-9. Arch Dermatol. 1981. PMID: 6945067
Cited by
-
Human in vivo pharmacology of topical retinoids.Arch Dermatol Res. 1994;287(1):53-60. doi: 10.1007/BF00370719. Arch Dermatol Res. 1994. PMID: 7726637 Review.
-
Preclinical assessment of dual CYP26[A1/B1] inhibitor, DX308, as an improved treatment for keratinization disorders.Skin Health Dis. 2021 Mar 26;1(2):e22. doi: 10.1002/ski2.22. eCollection 2021 Jun. Skin Health Dis. 2021. PMID: 35664983 Free PMC article.
-
The rhino mouse model: the effects of topically applied all-trans retinoic acid and CD271 on the fine structure of the epidermis and utricle wall of pseudocomedones.Arch Dermatol Res. 1991;283(2):100-7. doi: 10.1007/BF00371617. Arch Dermatol Res. 1991. PMID: 2069410
-
Gene expression of retinoic acid receptors and cellular retinoic acid-binding proteins in rhino and hairless mouse skin.Arch Dermatol Res. 1995;287(5):488-93. doi: 10.1007/BF00373433. Arch Dermatol Res. 1995. PMID: 7625860
-
Topical tazarotene for the treatment of ectropion in ichthyosis.JAMA Dermatol. 2013 May;149(5):598-600. doi: 10.1001/jamadermatol.2013.239. JAMA Dermatol. 2013. PMID: 23677086 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical